Characterization of an FTLD-PDB family with the coexistence of SQSTM1 mutation and hexanucleotide (G4C2) repeat expansion in C9orf72 gene

被引:24
|
作者
Almeida, Maria Rosario [1 ]
Letra, Liliana [2 ]
Pires, Paula [3 ]
Santos, Ana [1 ]
Rebelo, Olinda [4 ]
Guerreiro, Rita [5 ]
van der Zee, Julie [6 ,7 ]
Van Broeckhoven, Christine [6 ,7 ]
Santana, Isabel [1 ,2 ]
机构
[1] Univ Coimbra, Neurogenet Dept, CNC Ctr Neurosci & Cell Biol, P-3004548 Coimbra, Portugal
[2] Coimbra Univ Hosp, Dept Neurol, Coimbra, Portugal
[3] Hosp Santo Espirito Angra Heroismo, Dept Neurol, Azores, Portugal
[4] Coimbra Univ Hosp, Dept Neurol, Neuropathol Lab, Coimbra, Portugal
[5] UCL, Inst Neurol, Dept Mol Neurosci, London, England
[6] VIB, Dept Mol Genet, Neurodegenerat Brain Dis Grp, Antwerp, Belgium
[7] Univ Antwerp, Neurogenet Dept, Inst Born Bunge, B-2020 Antwerp, Belgium
关键词
Frontotemporal dementia; Paget disease of bone; C9orf72; SQSTM1; FRONTOTEMPORAL LOBAR DEGENERATION; AMYOTROPHIC-LATERAL-SCLEROSIS; UBIQUITIN-BINDING; PAGETS-DISEASE; DIAGNOSTIC-CRITERIA; DEMENTIA; BONE; P62; DEGRADATION; P62/SQSTM1;
D O I
10.1016/j.neurobiolaging.2015.12.015
中图分类号
R592 [老年病学]; C [社会科学总论];
学科分类号
03 ; 0303 ; 100203 ;
摘要
The C9orf72 expansion is considered a major genetic cause of familial frontotemporal dementia (FTD) in several patients' cohorts. Interestingly, C9orf72 expansion carriers, present also abundant neuronal p62-positive inclusions. Although p62/SQSTM1 mutations were initially associated with Paget disease of bone (PDB), they have been also identified in FTD. We describe an FTD-PDB family in which the proband presented with behavioral FTD phenotype and concomitant Paget disease. The molecular genetic analysis revealed the co-occurrence of 2 mutations; the pathogenic C9orf72 expansion and p.P392L heterozygous missense mutation in SQSTM1 gene. Amongst the 6 family members analyzed, the p.P392L SQSTM1 mutation segregated as expected with PDB, whereas the C9orf72 expansion segregated with frontal cognitive impairment or dementia in all but one carrier. The coexistence of these conditions could be underestimated since neither patients with FTD nor patients with PDB undergo bone scintigraphy or cognitive assessment, respectively. The number of cases with double mutations could also be over looked as the molecular strategy adopted in most laboratories ends with the identification of one pathogenic mutation in one of the known causative genes. Therefore, we advocate for further clinical and molecular evaluation in suspect cases. (C) 2016 Elsevier Inc. All rights reserved.
引用
收藏
页码:191.e1 / 191.e8
页数:8
相关论文
共 50 条
  • [1] Functional connectivity in patients with C9ORF72 hexanucleotide repeat expansion associated FTLD
    Rytty, Riika
    Nikkinen, Juha
    Tervonen, Osmo
    Remes, Anne
    Kiviniemi, Vesa
    DEMENTIA AND GERIATRIC COGNITIVE DISORDERS, 2012, 33 : 163 - 163
  • [2] Screening for C9ORF72 repeat expansion in FTLD
    Ferrari, Raffaele
    Mok, Kin
    Moreno, Jorge H.
    Cosentino, Stephanie
    Goldman, Jill
    Pietrini, Pietro
    Mayeux, Richard
    Tierney, Michael C.
    Kapogiannis, Dimitrios
    Jicha, Gregory A.
    Murrell, Jill R.
    Ghetti, Bernardino
    Wassermann, Eric M.
    Grafman, Jordan
    Hardy, John
    Huey, Edward D.
    Momeni, Parastoo
    NEUROBIOLOGY OF AGING, 2012, 33 (08) : 1850.e1 - 1850.e11
  • [3] Incidence and penetrance of C9orf72 hexanucleotide repeat expansion in Swedish FTLD cases and families
    Thonberg, Hakan
    Chiang, Huei-Hsin
    van der Zee, Julie
    Ferrari, Raffaele
    Mok, Kin
    Van Broeckhoven, Christine
    Graff, Caroline
    DEMENTIA AND GERIATRIC COGNITIVE DISORDERS, 2012, 33 : 90 - 91
  • [4] Clinical and Imaging Findings in a Family with Hexanucleotide Repeat Expansion in C9ORF72
    Viitanen, Matti
    Almkvist, Ove
    Tuominen, Hannu
    Karlsson, Goran
    Myllykangas, Liisa
    Poyhonen, Minna
    Rinne, Juha
    DEMENTIA AND GERIATRIC COGNITIVE DISORDERS, 2012, 33 : 242 - 243
  • [5] The C9orf72 hexanucleotide repeat expansion in FTD and ALS
    Eileen H. Bigio
    Nature Reviews Neurology, 2012, 8 : 249 - 250
  • [6] Hypermethylation of the CpG Island Near the G4C2 Repeat in ALS with a C9orf72 Expansion
    Xi, Zhengrui
    Zinman, Lorne
    Moreno, Danielle
    Schymick, Jennifer
    Liang, Yan
    Sato, Christine
    Zheng, Yonglan
    Ghani, Mandi
    Dib, Samar
    Keith, Julia
    Robertson, Janice
    Rogaeva, Ekaterina
    AMERICAN JOURNAL OF HUMAN GENETICS, 2013, 92 (06) : 981 - 989
  • [7] The C9orf72 hexanucleotide repeat expansion in FTD and ALS
    Bigio, Eileen H.
    NATURE REVIEWS NEUROLOGY, 2012, 8 (05) : 249 - 250
  • [8] Somatic and intergenerational G4C2 hexanucleotide repeat instability in a human C9orf72 knock-in mouse model
    Kojak, Nada
    Kuno, Junko
    Fittipaldi, Kristina E.
    Khan, Ambereen
    Wenger, David
    Glasser, Michael
    Donnianni, Roberto A.
    Tang, Yajun
    Zhang, Jade
    Huling, Katie
    Ally, Roxanne
    Mujica, Alejandro O.
    Turner, Terrence
    Magardino, Gina
    Huang, Pei Yi
    Kerk, Sze Yen
    Droguett, Gustavo
    Prissette, Marine
    Rojas, Jose
    Gomez, Teodoro
    Gagliardi, Anthony
    Hunt, Charleen
    Rabinowitz, Jeremy S.
    Gong, Guochun
    Poueymirou, William
    Chiao, Eric
    Zambrowicz, Brian
    Siao, Chia-Jen
    Kajimura, Daisuke
    NUCLEIC ACIDS RESEARCH, 2024, 52 (10) : 5732 - 5755
  • [9] Refining the Clinical Presentation of the C9ORF72 Hexanucleotide Repeat Expansion
    Miller, Bruce L.
    BIOLOGICAL PSYCHIATRY, 2013, 74 (05) : 320 - 320
  • [10] C9orf72 hexanucleotide repeat expansion in Turkish ALS patients
    Iskender, C.
    Eken, A. Gundogdu
    Ozoguz, A.
    Akimoto, C.
    Alstermark, H.
    Andersen, P. M.
    Basak, A. N.
    JOURNAL OF NEUROLOGY, 2014, 261 : S222 - S222